Search for: "Teva Pharmaceuticals"
Results 741 - 760
of 1,429
Sort by Relevance
|
Sort by Date
15 Jul 2013, 8:50 pm
Teva Parenteral Medicines, Inc., et al., C.A. [read post]
14 Jul 2013, 9:23 pm
• Defendants: Teva Pharmaceuticals USA Inc.; Teva Pharmaceutical Industries Ltd. [read post]
5 Jul 2013, 5:00 am
Teva Parental Medicines, Inc., 795 F. [read post]
29 Jun 2013, 8:43 am
One relates to perindopril in which Servier, Teva, Mylan and several others are in the Commission’s sights, and the other relates to fentanyl, where Johnson & Johnson and Novartis / Sandoz are involved. [read post]
18 Jun 2013, 9:17 am
About 12 per cent of respondents were from Canadian companies.The survey shows corporate counsel seek to add value to the business by adopting new tactics to meet their goal, including:• Redefining strategies to obtain permits and regulatory approvals faster;• Planning for acquisitions before the business units engage in talks;• Sitting on research and development committees to spot IP opportunities earlier;• Developing settlement decision trees to get to resolution faster;… [read post]
14 Jun 2013, 8:42 am
Further details may be obtained by emailing the KsIIP at kosovoip@gmail.com This Kat was thrilled to hear the news today that his friend Dr Galit Gonen, who heads up Teva's European litigation team, was voted ILO Global IP Counsel of the Year in New York last night. [read post]
10 Jun 2013, 8:20 pm
The one-pill version is made by Teva Pharmaceutical Products. [read post]
20 May 2013, 11:52 pm
Mylan concerning fexofenadine.The decision is by a 2-1 vote.The initial part of the decision:Aventis Pharmaceuticals, Inc. and Albany MolecularResearch, Inc. [read post]
9 May 2013, 5:34 am
The lawsuit names Pfizer, as well as two different generic drug manufacturers - Actavis Elizabeth and Teva Pharmaceuticals - in the U.S. [read post]
3 Apr 2013, 4:45 am
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
1 Apr 2013, 8:29 am
” Upon receiving this reissue patent, Pfizer immediately filed a lawsuit against Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Lupin Pharmaceuticals, USA, Inc.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
17 Mar 2013, 9:39 pm
• Defendants: Teva Pharmaceutical Industries, Ltd.; Teva Pharmaceuticals USA, Inc. [read post]
10 Mar 2013, 9:59 pm
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
20 Feb 2013, 7:37 am
Teva Pharmaceuticals USA Inc., et. al., 1-10-cv-00805 (DED February 11, 2013, Order) (Burke, M.J.). [read post]
18 Feb 2013, 12:46 am
Yusuf Hamied is the Chairman of Cipla and, is also known as the Grand Old Man of the Indian Pharmaceuticals Industry. [read post]
15 Feb 2013, 9:29 am
Teva Pharmaceuticals USA, Inc., C.A. [read post]
13 Feb 2013, 11:49 pm
The invalidation was pursuant to a law suit bought by BMS (the patentee) against Teva, a leading Israeli generic company. [read post]
8 Feb 2013, 11:04 am
Teva Pharmaceuticals USA, Inc., et. al., 1-10-cv-01796 (NYSD February 6, 2013, Order) (Sullivan, J.). [read post]
1 Feb 2013, 9:42 am
Wyeth Pharmaceuticals, Inc. [read post]
29 Jan 2013, 9:21 pm
By Micheal Greenfield -- Those of you who dabble with chemical structures while prosecuting or litigating pharmaceutical patents may find Allergan v. [read post]
